全文获取类型
收费全文 | 3047篇 |
免费 | 145篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 97篇 |
妇产科学 | 99篇 |
基础医学 | 488篇 |
口腔科学 | 82篇 |
临床医学 | 228篇 |
内科学 | 737篇 |
皮肤病学 | 81篇 |
神经病学 | 162篇 |
特种医学 | 33篇 |
外科学 | 254篇 |
综合类 | 28篇 |
一般理论 | 1篇 |
预防医学 | 407篇 |
眼科学 | 53篇 |
药学 | 259篇 |
中国医学 | 16篇 |
肿瘤学 | 157篇 |
出版年
2023年 | 25篇 |
2022年 | 61篇 |
2021年 | 95篇 |
2020年 | 50篇 |
2019年 | 74篇 |
2018年 | 81篇 |
2017年 | 72篇 |
2016年 | 63篇 |
2015年 | 75篇 |
2014年 | 128篇 |
2013年 | 175篇 |
2012年 | 269篇 |
2011年 | 243篇 |
2010年 | 142篇 |
2009年 | 114篇 |
2008年 | 200篇 |
2007年 | 226篇 |
2006年 | 188篇 |
2005年 | 177篇 |
2004年 | 163篇 |
2003年 | 171篇 |
2002年 | 163篇 |
2001年 | 23篇 |
2000年 | 16篇 |
1999年 | 20篇 |
1998年 | 28篇 |
1997年 | 20篇 |
1996年 | 18篇 |
1995年 | 13篇 |
1994年 | 11篇 |
1993年 | 12篇 |
1992年 | 5篇 |
1991年 | 3篇 |
1990年 | 9篇 |
1989年 | 6篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1981年 | 3篇 |
1978年 | 3篇 |
1975年 | 4篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1968年 | 2篇 |
1967年 | 3篇 |
1926年 | 1篇 |
排序方式: 共有3201条查询结果,搜索用时 31 毫秒
101.
Ji‐Guang Wang Ma Lourdes Bunyi Yook Chin Chia Kazuomi Kario Takayoshi Ohkubo Sungha Park Apichard Sukonthasarn Jam Chin Tay Yuda Turana Narsingh Verma Tzung‐Dau Wang Yutaka Imai 《Journal of clinical hypertension (Greenwich, Conn.)》2021,23(1):3-11
Hypertension is one of the most powerful modifiable risk factors for cardiovascular disease. It is usually asymptomatic and therefore essential to measure blood pressure regularly for the detection of hypertension. Home blood pressure monitoring (HBPM) is recognized as a valuable tool to monitor blood pressure and facilitate effective diagnosis of hypertension. It is useful to identify the masked or white‐coat hypertension. There is also increasing evidence that supports the role of HBPM in guiding antihypertensive treatment, and improving treatment compliance and hypertension control. In addition, HBPM has also shown prognostic value in predicting cardiovascular events. Despite these benefits, the use of HBPM in many parts of Asia has been reported to be low. An expert panel comprising 12 leading experts from 10 Asian countries/regions convened to share their perspectives on the realities of HBPM. This article provides an expert summary of the current status of HBPM and the key factors hindering its use. It also describes HBPM‐related initiatives in the respective countries/regions and presents strategies that could be implemented to better support the use of HBPM in the management of hypertension. 相似文献
102.
103.
Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline 总被引:2,自引:0,他引:2
Martin KA Chang RJ Ehrmann DA Ibanez L Lobo RA Rosenfield RL Shapiro J Montori VM Swiglo BA 《The Journal of clinical endocrinology and metabolism》2008,93(4):1105-1120
OBJECTIVE: Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. PARTICIPANTS: The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, two methodologists, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations, and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and e-mail communications. The drafts prepared by the Task Force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We suggest testing for elevated androgen levels in women with moderate or severe hirsutism or hirsutism of any degree when it is sudden in onset, rapidly progressive, or associated with other abnormalities such as menstrual dysfunction, obesity, or clitoromegaly. For women with patient-important hirsutism despite cosmetic measures, we suggest either pharmacological therapy or direct hair removal methods. For pharmacological therapy, we suggest oral contraceptives for the majority of women, adding an antiandrogen after 6 months if the response is suboptimal. We recommend against antiandrogen monotherapy unless adequate contraception is used. We suggest against using insulin-lowering drugs. For women who choose hair removal therapy, we suggest laser/photoepilation. 相似文献
104.
Hugo González Saldivar Lourdes Vicent Alaminos Carlos Rodríguez-Pascual Gonzalo de la Morena Covadonga Fernández-Golfín Carmen Amorós Mario Baquero Alonso Luis Martínez Dolz Albert Ariza Solé Gabriela Guzmán-Martínez Juan José Gómez-Doblas Antonio Arribas Jiménez María Eugenia Fuentes Laura Galian Gay Martín Ruiz Ortiz Pablo Avanzas Emad Abu-Assi Tomás Ripoll-Vera Manuel Martínez-Sellés 《Revista espa?ola de cardiología》2019,72(5):392-397
Introduction and objectives
Current therapeutic options for severe aortic stenosis (AS) include transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). Our aim was to describe the prognosis of patients with severe AS after the decision to perform an intervention, to study the variables influencing their prognosis, and to describe the determinants of waiting time > 2 months.Methods
Subanalysis of the IDEAS (Influence of the Severe Aortic Stenosis Diagnosis) registry in patients indicated for TAVI or SAVR.Results
Of 726 patients with severe AS diagnosed in January 2014, the decision to perform an intervention was made in 300, who were included in the present study. The mean age was 74.0 ± 9.7 years. A total of 258 (86.0%) underwent an intervention: 59 TAVI and 199 SAVR. At the end of the year, 42 patients (14.0%) with an indication for an intervention did not receive it, either because they remained on the waiting list (34 patients) or died while waiting for the procedure (8 patients). Of the patients who died while on the waiting list, half did so in the first 100 days. The mean waiting time was 2.9 ± 1.6 for TAVI and 3.5 ± 0.2 months for SAVR (P = .03). The independent predictors of mortality were male sex (HR, 2.6; 95%CI, 1.1-6.0), moderate-severe mitral regurgitation (HR, 2.6; 95%CI, 1.5-4.5), reduced mobility (HR, 4.6; 95%CI, 1.7-12.6), and nonintervention (HR, 2.3; 95%CI, 1.02-5.03).Conclusions
Patients with severe aortic stenosis awaiting therapeutic procedures have a high mortality risk. Some clinical indicators predict a worse prognosis and suggest the need for early intervention. 相似文献105.
106.
107.
Teresa Juárez-Cedillo Lourdes Basurto-Acevedo Sara Vega-García Leticia Manuel-Apolinar Emiliano Cruz-Tesoro José Manuel Rodríguez-Pérez Normand García-Hernández Nonanzit Pérez-Hernández José Manuel Fragoso 《Annals of hematology》2014,93(12):2057-2062
Anemia represents a global health problem that negatively impacts quality of life in elderly population; however, its impact on the geriatric syndrome of frailty is unclear. We examined the prevalence of anemia among elderly and sought a relationship between hemoglobin and the phenotype of frailty. Baseline hemoglobin quintiles and anemia were assessed in relation to frailty status in a prospective study with 1,933 older community-dwelling adults enrolled in the Study on Aging and Dementia in Mexico (SADEM). Logistic regression was used to model the relationship between frailty and Hb, adjusting for risk factors of frailty, sociodemographic data, cognitive decline, chronic diseases, and some risky habits. Prevalence of frailty was 8.3 %. Frailty risk was highest at the lowest hemoglobin quintile (<14.3 g/dL for men; <13.3 g/dL for women), and 160 (8.3 %) were anemic (<13 g/dL for men; <12 g/dL for women). The relationship between frailty and Hb levels, adjusted for age and sex, observed in the first and fifth quintiles, compared with the fourth quintile, were 1.53 (95 % confidence interval (CI), 1.46–1.60) and 1.05 (95 % CI, 1.01–1.15). After multivariate adjustment, the odds ratios (ORs) were 1.23 (95 % CI, 1.17–1.13) and 1.06 (95 % CI, 1.01–1.11). The association was not diminished by risk factors for frailty (body mass index (BMI), comorbidity, cognitive decline, smoking, alcohol consumption, etc.). In community-dwelling older adults, low hemoglobin concentrations and anemia were independently associated with increased frailty risk. This suggests that mild anemia and low Hb levels are independent, modifiable risk factors for frailty. 相似文献
108.
Lourdes Calvente Rosemarie Tremblay-LeMay Wei Xu Fong Chun Chan Michael Hong Tong Zhang Ho-Young Yhim John Kuruvilla Michael Crump Vishal Kukreti Anca Prica Dean Regier Marco A. Marra Aly Karsan Christian Steidl David W. Scott Peter Sabatini Robert Kridel 《British journal of haematology》2020,190(6):864-868
Despite continuing improvements in the management of classical Hodgkin lymphoma (cHL), relapse remains associated with a risk of lymphoma-related mortality. The biological composition of relapse tumour biopsies shows interpatient variability, which can be leveraged to design prognostic biomarkers. Here, we validated the RHL30 assay, a previously reported gene expression model in an independent cohort of 41 patients with relapsed cHL. Patients classified as high-risk by the RHL30 assay had inferior failure-free survival (FFS) after autologous stem cell transplantation (2-year FFS 41% vs. 92%, P = 0·035). The RHL30 model is a robust biomarker that risk-stratifies patients considered for autologous stem cell transplantation. 相似文献
109.
Yumary Ruiz Vincent Guilamo-Ramos Katharine McCarthy Miguel A. Mu?oz-Laboy Maria de Lourdes Rosas López 《American journal of public health》2014,104(6):1036-1044
Migration and population movement are increasingly viewed as important factors associated with HIV transmission risk. With growing awareness of the potential impact of migration on HIV transmission, several perspectives have emerged that posit differing dynamics of risk. We considered available data on the role of migration on HIV transmission among Mexican migrants in New York City and Puebla, Mexico. Specifically, we examined 3 distinct models of migratory dynamics of HIV transmission—namely, the structural model, the local contextual model, and the interplay model. In doing so, we reframed current public health perspectives on the role of migration on HIV transmission.The epidemiological literature related to Latinos and HIV in the United States highlights geographic disparities in disease burden.1 HIV/AIDS cases among Latinos are clustered geographically, such that Latinos experience increased vulnerability as a function of residence in high-risk physical and geographic areas.2 Recent trends in HIV infection demonstrate that Latino mobility and migratory patterns are potentially associated with increased HIV incidence.3 As a result, several key dynamics to account for the role of migration and HIV transmission have emerged in recent literature. However, to adequately address the current HIV epidemic among Latinos, greater consideration of each of these mechanisms and enhanced attention to the role of geography and migration is warranted.4 Recent findings increasingly draw attention to the role of population mixing and movement, geography, and other physical spaces as important factors for understanding Latino HIV disparities.5 We build upon this work by examining the available empirical literature on HIV and migration in relation to the social structures and contexts in which risk behavior takes place. Specifically, we explored 3 mechanisms for the impact of migration on HIV transmission through the case of Mexican migrants in New York City (NYC) and Puebla.As the epicenter of the HIV/AIDS epidemic in the United States, NYC is one such high-risk geographic area.6 New York City has an incidence rate 3 times the national average and the highest number of AIDS cases relative to any other metropolitan city.6 Latinos in the city are disproportionately affected by the disease and are twice as likely to be diagnosed with HIV/AIDS compared with non-Hispanic Whites.7 Furthermore, although Latinos account for approximately 25% of the population in NYC, they represent 33% of NYC persons living with HIV/AIDS (PLWHA).8,9 Among NYC Latinos, HIV occurs primarily among adults through high-risk sexual behavior and intravenous drug use.10 Specifically, Latino men who have sex with men (MSM) constitute the majority of cases (40%), followed by injection drug users (27%).10 These data suggest that in NYC, Latino MSM and intravenous drug users bear the burden of HIV disease. However, a significant proportion of Latina women in NYC infected with HIV are exposed through high-risk sexual activity (67%) and represents a steady proportion of new HIV diagnoses among women in recent years.11HIV/AIDS is of particular concern among Latinos as they are more likely to experience delays in access to care, which results in adverse health outcomes. For example, Latinos, particularly Mexicans with low levels of acculturation, are less likely to obtain an HIV test.12 Those who are diagnosed often experience rapid progression to AIDS, suggesting that many Latinos are diagnosed late in their infection.6 In 2011, for example, 31% of Latinos diagnosed with HIV in NYC were concurrently diagnosed with AIDS, compared with only 15% of Whites.11 Late diagnosis puts Latinos at greater health risks because they do not receive the benefits of early antiretroviral treatment.13 In addition to late diagnosis and delayed treatment, obstacles in access to HIV treatment for Latinos include lack of a designated routine health care provider and adequate health insurance.14Increasingly, the Latino population in NYC has undergone important demographic changes.15 Specifically, migratory changes have shifted the composition of the Latino population in NYC, introducing new Latino subgroups to a geographic area of heightened HIV risk. Traditionally, the Latino population in NYC has been classified as largely stemming from the Caribbean—specifically, Puerto Rico and the Dominican Republic. However, Mexicans, whose US migration patterns have traditionally been associated with the areas of the Southwest, are increasingly moving to NYC, a nontraditional receiving community.For example, the Mexican population in NYC in 2010 was more than 5 times what it was in 1990.16 In 1990, an estimated 56 700 Mexicans were living in NYC; by 2000, this number grew to 180 000, and later to 325 000 in 2010.16 Foreign-born males with less than a high-school education represent the bulk of the Mexican population growth and a significant portion of this population attains employment in NYC.15 By 2024, it is predicted that Mexicans will be the most populous Latino ethnic subgroup in the largest city of the United States.17 One notable feature of NYC’s Mexican community is that nearly half (45%) originates from the state of Puebla in east-central Mexico, although other sources suggest far higher proportions (more than 70%).18 Data from the American Community Survey demonstrate that Mexican-born persons are geographically clustered in specific target communities, predominantly the Bronx and Queens (Figure 1).19Open in a separate windowFIGURE 1—Foreign-born from Mexico by Public Use Microdata Areas in New York City: 2006–2008.Note. PUMA = Public Use Microdata Area.Source. US Census Bureau.20 相似文献
110.
Daniel Ortuño-Sahagún Raúl Montes González Ester Verdaguer Verónica Chaparro Huerta Blanca M. Torres-Mendoza Lourdes Lemus Martha Catalina Rivera-Cervantes A. Camins C. Beas Zárate 《Journal of molecular neuroscience : MN》2014,52(3):366-377
Current knowledge concerning the molecular mechanisms of the cellular response to excitotoxic insults in neurodegenerative diseases is insufficient. Although glutamate (Glu) has been widely studied as the main excitatory neurotransmitter and principal excitotoxic agent, the neuroprotective response enacted by neurons is not yet completely understood. Some of the molecular participants have been revealed, but the signaling pathways involved in this protective response are just beginning to be identified. Here, we demonstrate in vivo that, in response to the cell damage and death induced by Glu excitotoxicity, neurons orchestrate a survival response through the extracellular signal-regulated kinase (ERK) signaling pathway by increasing ERK expression in the rat hippocampal (CA1) region, allowing increased neuronal survival. In addition, this protective response is specifically reversed by U0126, an ERK inhibitor, which promotes cell death only when it is administered together with Glu. Our findings demonstrate that the ERK signaling pathway has a neuroprotective role in the response to Glu-induced excitotoxicity in hippocampal neurons. Therefore, the ERK signaling pathway may be activated as a cellular response to excitotoxic injury to prevent damage and neural loss, representing a novel therapeutic target in the treatment of neurodegenerative diseases. 相似文献